Skip to main content

Home/ MaRS/ Group items tagged Imaging

Rss Feed Group items tagged

George Botos

FDA action may rain on iPhone's medical imaging parade - 0 views

  •  
    Interest is booming in the use of mobile devices such as Apple's iPhone for image viewing applications. But that excitement may be dampened somewhat with a recent U.S. Food and Drug Administration (FDA) decision to classify an iPhone image viewing application as a class III device requiring premarket approval.
George Botos

SonoSite buys VisualSonics for $71M - 0 views

  •  
    Adult digital artery imaged with a conventional high frequency linear transducer (200 micron resolution). Image Source: SonoSite SonoSite, a developer of point-of-care ultrasound systems, today signed an agreement to acquire privately held Visualsonics, a Toronto-based company focused on high-frequency micro-ultrasound technology, in a transaction approximately valued at $71 million net of cash and debt.
Assunta Krehl

Life Science Cluters magazine - 0 views

  •  
    Claron Technologies develops and provides imaging processing solutions for the medical imaging industry. Claron Technologies outlines how MaRS Discovery District has helped them to reach their success.
Assunta Krehl

Physicist pairs with pharmaceutical scientist to design nano-particles for cancer imagi... - 0 views

  •  
    A pair of Toronto scientists has developed a unique technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Nov 20, 2009
Assunta Krehl

Physicist pairs with pharmaceutical scientist to design nano-particles for cancer imagi... - 0 views

  •  
    A pair of Toronto scientists has developed a unique technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Nov 19, 2009
Assunta Krehl

Segasist Technology - Business News - After Hours - 0 views

  •  
    Segasist Technology has developed special software for doctors to help read medical images. Jaqueline Csonka-Peeren, president and CEO, Segasist Technology tells BNN more. Nov 6, 2009
Melissa Hughes

Figure1 app not for the faint of heart as doctors upload gruesome images | Canada | New... - 0 views

  •  
    "Figure1 is a new photo-sharing network specifically for health professionals: cute cats, vacation scenes and other mainstays of social media are nowhere to be found."
Assunta Krehl

U.S. and Canadian Scientists Form a Global Alliance for Nano-Bio-Electronics ... - 0 views

  •  
    The Society for Brain Mapping and Therapeutics (SBMT) announced today that the organization will hold its 9th Annual World Congress on Brain, Spinal Cord Mapping, and Image Guided Therapy from June 2-4, 2012 in Toronto, Canada. MaRS Innovation is one of the supporters for the conference.
Assunta Krehl

U.S. and Canadian Scientists Form a Global Alliance for Nano-Bio-Electronics in Order t... - 0 views

  •  
    The Society for Brain Mapping and Therapeutics (SBMT) announced today that the organization will hold its 9th Annual World Congress on Brain, Spinal Cord Mapping, and Image Guided Therapy from June 2-4, 2012 in Toronto, Canada. Parimal Nathwani, Vice President of MaRS Innovation, says"Forums like this represent an excellent opportunity for reviewing technologies and supporting collaboration across different institutions for more effective translation and commercialization opportunity."
Assunta Krehl

Canadian Incubation Center Brings Five Cleantech Startups To Boston Forum - CleanTechBrief - 0 views

  • MaRS, a Toronto-based, not-for-profit incubation center, is leading a delegation of five cleantech ventures at this week’s Cleantech Forum XXIII in Boston. The companies – all clients of MaRS advisory services – will showcase their products for the cleantech CEOs, investors, scientists and policy makers attending the east coast forum. “While cleantech is a relatively new sector for MaRS advisory services, it is fast catching up with our other core strengths in information technologies and life sciences,” said Tom Rand, a cleantech entrepreneur, author and investor who leads MaRS’ cleantech practice. “MaRS is establishing itself as a major deal-flow engine in the cleantech sector, with an emphasis on early-stage companies.”
  • Alternative Fuels
  • Nimtech
  • ...4 more annotations...
  • Real Tech
  • Skymeter
  • Vicicog
  • MaRS Discovery District is a large scale, mission-driven innovation center focused on building Canada’s next generation of technology companies.
  •  
    MaRS is leading a delegation of five cleantech ventures at this week's (Sept 8 o 10) Cleantech Forum XXIII in Boston. The presenting companies from MaRS are: Alternative Fuels (deriving energy from waste), Nimtech (eco-friendly chemical process control), Real Tech (organic water testing), Skymeter (pay-as-you-drive GPS metering) and Vicicog (efficient wind turbine transmission systems). Sept 11, 2009
  •  
    MaRS is leading a delegation of five cleantech ventures at this week's (Sept 8 o 10) Cleantech Forum XXIII in Boston. The presenting companies from MaRS are: Alternative Fuels (deriving energy from waste), Nimtech (eco-friendly chemical process control), Real Tech (organic water testing), Skymeter (pay-as-you-drive GPS metering) and Vicicog (efficient wind turbine transmission systems). Sept 11, 2009
Sarah Hickman

The Design of Things to Come: How Ordinary People Create Extraordinary Products: Amazon... - 0 views

  •  
    The iPod is a harbinger of a revolution in product design: innovation that targets customer emotion, self-image, and fantasy, not just product function. Read the hidden stories behind BodyMedia's SenseWear body monitor, Herman Miller's Mirra Chair, Swiffer's mops, OXO's potato peelers, Adidas' intelligent shoes, the new Ford F-150 pickup truck, and many other winning innovations. Meet the innovators, learning how they inspire and motivate their people, as they shepherd their visions through corporate bureaucracy to profitable reality. The authors deconstruct the entire process of design innovation, showing how it really works, and how today's smartest companies are innovating more effectively than ever before.
Assunta Krehl

Lab Canada - * Printer friendly version * Email story to a friend * Send ... - 0 views

  •  
    To improve early detection and treatment of cancer, a pair of Toronto scientists, Dr David Jaffray, a senior scientist in the division of biophysics and bioimaging at the Ontario Cancer Institute and Dr Christine Allen, an associate professor in the Leslie Dan Faculty of Pharmacy at the University of Toronto has developed a technology that combines contrast agents with targeted, long-lasting nano-particles for use in multiple medical imaging platforms. MaRS Innovation (MI) and the University Health Network (UHN) have now entered into an agreement to collaboratively commercialize this promising technology. Dec 23, 2009
Melissa Hughes

This Is What 'Instagram for Doctors' Looks Like - The Atlantic - June 12, 2013 - 0 views

  •  
    "Dr. Joshua Landy is envisioning a new way for doctors to learn from one another. A Toronto-based intensive care physician by trade, Landy is the co-founder of Figure 1, a "crowdsourced photo sharing app for health care professionals." Launched just two weeks ago, the iPhone app is already populated with images both clinically significant and arguably beautiful -- without even the benefit of a filter."
Assunta Krehl

Recap: Startup Drinks & Entrepreneurship 101 Life Sciences & Healthcare - lidiasworld -... - 1 views

  •  
    LidiasWorld blogs about the Entrepreneurship 101 class she and her partner attended at MaRS with guest speaker Dr. Stuart Foster, the founder of VisualSonics, spoke mainly about the challenges of being a science tech specific startup.
Assunta Krehl

Test-tube industry - Canadian Business - 0 views

  • For Dr. John Evans, growing a strong biotechnology industry is much the same: cities must provide a nurturing environment where science and business can thrive together.
  • That's why Evans, former president of the University of Toronto and current chairman of Torstar Corp., is spearheading the $345-million Medical and Related Science initiative, or MaRS--a petri dish of sorts for commercializing science research. "A lot of intellectual property is being commercialized outside Canada," says Evans. "I think we've been slow in realizing just how important technology developments are to the economic future of the country. MaRS is an attempt to give this a kick into a higher gear." The centrepiece of the MaRS plan, which will officially launch May 12, is a 1.3-million-square-foot, five-building complex in downtown Toronto that will provide office and lab space for small and medium-size companies and incubators, including the not-for-profit Toronto Biotechnology Commercialization Centre. While Evans is reluctant to limit its scope, MaRS will generally focus on health-related technologies, from new drugs and genetic treatments to medical devices and imaging software. Branded a "convergence centre," it will also house a careful mix of support services: intellectual property lawyers, accountants, marketing experts, government funding organizations and venture capital financiers. Plus, start-ups will have access to all the latest equipment on site. For instance, MaRS is in talks with MDS Sciex to supply mass spectrometers, used in proteomics research.
  • But MaRS will be more than just a New Economy real estate development. Evans's intention is to funnel tenants' rent money into services--such as entrepreneurship seminars and angel-matching programs--that MaRS will offer to the broader biotech community. That's why MaRS's location is key: the centre will be built in the heart of what Toronto has dubbed the "Discovery District," a two-square-kilometre chunk of the downtown core, encompassing U of T and four major hospitals. From there, MaRS hopes to act as a network hub across Ontario, with links to research-intensive universities. "None of them," says Evans, "have the critical mass to put it all together on their own."
  • ...3 more annotations...
  • MaRS's primary goal is to get Toronto and the rest of Ontario on the global biotech map. Evans came up with the concept in the late 1990s with Dr. Calvin Stiller, CEO of the labor-sponsored Canadian Medical Discoveries Fund, and Kenneth Knox, a former deputy minister for the Ontario government who's now CEO of MaRS
  • As far as schemes to support fledgling industries go, MaRS is refreshing. To start, it's a nonprofit corporation, not a government program, which will hopefully ensure that it runs more efficiently. The feds and the province of Ontario have each doled out $20 million for MaRS, and Toronto has donated in-kind $4.5 million. More than $12 million has come from a small pool of corporations, including Eli Lilly Canada and MDS, as well as individual donors like Joseph Rotman and Lawrence Bloomberg (who both sit on the MaRS board). U of T pitched in $5 million, and MaRS also did some innovative bond financing to round off the $165 million needed to build Phase I. "It was very important for us to not belong to anybody," says Evans.
  • Now MaRS's challenge is to get the word out. Its posted rate of $26 per square foot is very competitive for prime downtown real estate and is sure to attract attention, especially considering its customized lab space. But MaRS's success won't be measured by a low vacancy rate; getting the right mix of scientists, entrepreneurs and professionals is critical if it plans to commercialize some sustainable businesses. It won't happen overnight--in fact, it may be 10 years before anyone can gauge MaRS's impact. Seems growing a biotech industry isn't quite as easy as growing E. coli in a petri dish.
  •  
    John Evans spearheads the MaRS project which will help to accelerate commercialization for scientific research. The official launch of the MaRS plan will happen on May 12, 2003.
Assunta Krehl

Travel-bug research urged - The Star - 0 views

  •  
    As stated in the Toronto Staf, according to Kain, Director at the centre for Travel and Tropical Medicine at Toronto General Hospital, "Toronto officials should study travelers and the illnesses the bring back to understand and cope with widespread outbreaks of diseases."
  •  
    As stated in the Toronto Star, according to Kain, Director at the centre for Travel and Tropical Medicine at Toronto General Hospital, "Toronto officials should study travelers and the illnesses the bring back to understand and cope with widespread outbreaks of diseases." Nov 11, 2005
Assunta Krehl

New hormones study results from D. Islam et al described - HighBeam Research - 0 views

  •  
    Islam D, Zhang N, Wang P, Li H, Brubaker PL, Gaisano HY, Wang Q, Jin T. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines. The research lab is located in teh MaRS Centre.
  •  
    Islam D, Zhang N, Wang P, Li H, Brubaker PL, Gaisano HY, Wang Q, Jin T. Epac is involved in cAMP-stimulated proglucagon expression and hormone production but not hormone secretion in pancreatic alpha- and intestinal L-cell lines. The research lab is located in teh MaRS Centre. March 4, 2009
Assunta Krehl

Research from P.B. Stathopulos and colleagues has provided new data on biological chemi... - 0 views

  •  
    Research from P.B. Stathopulos and colleagues has provided new data on biological chemistry.
  •  
    Research from P.B. Stathopulos and colleagues has provided new data on biological chemistry. March 6, 2009
Assunta Krehl

SqueezePlay : May 5, 2009 : [05-05-09 5:00PM] - 0 views

  •  
    BNN talks to Niall Wallace, CEO, Infonaut Inc. about their invention of mapping out infectious diseases. Brief mention about MaRS.
George Botos

Investing in innovative Medical research - 0 views

  •  
    whitepaper on investment sources for medical research
1 - 20 of 25 Next ›
Showing 20 items per page